FDA.reportPublic FDA data

Application 077224

Type
ANDA
Sponsor
ZYDUS PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RIBAVIRINRIBAVIRINCAPSULE;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
53808-0782RibavirinRIBAVIRINState of Florida DOH Central PharmacyANDACurrent
65841-260RibavirinRibavirinCadila Healthcare LimitedANDACurrent
65841-260RibavirinRibavirinZydus Lifesciences LimitedANDACurrent
65841-260RibavirinRibavirinCadila Healthcare LimitedANDACurrent
65841-260RibavirinRibavirinCadila Healthcare LimitedANDACurrent
68084-179RibavirinRibavirinAmerican Health PackagingANDACurrent
68382-260RibavirinRibavirinZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-260RibavirinRibavirinZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-260RibavirinRibavirinZydus Pharmaceuticals USA Inc.ANDACurrent